Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Boehringer Ingelheim and Zai Lab launch a clinical collaboration to evaluate a dual DLL3‑targeting combination therapy in small cell lung cancer (SCLC) and other neuroendocrine carcinomas (NECs). ...
-
• VB4-P5 – novel new chemical entity with potential to address significant unmet need in rare and large-market chronic kidney disease • CALGARY, Alberta, April 13, 2026 (GLOBE NEWSWIRE) -- XORTX...
-
Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Zynyz Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
-
Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Dementia - Market Insight, Epidemiology, and Market Forecast - 2034" has been added to ResearchAndMarkets.com's offering. Dementia, primarily...
-
Vancouver, Canada, April 10, 2026 (GLOBE NEWSWIRE) -- Finding a reliable platform among no deposit bonus casinos often feels like a gamble in itself, with many players frustrated by "phantom...
-
WASHINGTON, April 09, 2026 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Siemens Healthineers, a leading global medical technology provider pioneering...
-
Boehringer Ingelheim to evaluate innovative combination of DLL3‑targeting T‑cell engager plus PD‑L1/VEGF‑A bispecific antibody in small cell lung cancer.
-
EMERYVILLE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Kyverna, Nasdaq: KYTX), a late-stage clinical biopharmaceutical company focused on developing cell therapies for...
-
Sling Essentials delivers top-tier sports, family programming, and classic TV—including ESPN and more—for an unbeatable price of $19.99 a month.
-
CEO Charles Allen will participate in the upcoming Water Tower Research Insights Conference on April 14, 2026, at 1:50 p.m. Eastern Time.